Status:
COMPLETED
Evaluating The Cardiovascular Effects of Tourniquet Application
Lead Sponsor:
Merve Şeker
Collaborating Sponsors:
Acibadem University
Conditions:
Orthopedic Disorder
Hemodynamic Instability
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this prospective observational study is to investigate the impact of tourniquet application on cardiac efficiency through the cardiac cycle efficiency parameter and to explore how central ...
Detailed Description
After obtaining ethical committee approval (ATADEK; 2022-14/12), 43 patients undergoing elective unilateral total knee arthroplasty under tourniquet were enrolled in our prospective observational stud...
Eligibility Criteria
Inclusion
- Planned for Elective Unilateral Total Knee Arthroplasty Under Tourniquet Application
- Aged 18 and over
- Either general anesthesia (GA) or combined spinal-epidural anesthesia (CSEA) will be administered
Exclusion
- Patients under 18 years of age
- Patients with heart failure
- Patients with valve disease
- Patients with rhythm disorders
- Patients with a history of myocardial infarction in the last 3 months
- Patients unwilling to provide consent
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT06158165
Start Date
September 1 2022
End Date
April 1 2023
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acibadem University
Istanbul, Üsküdar, Turkey (Türkiye), 34662